These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 23229661

  • 1. [Tacrolimus: secondary or main player in children with steroid-resistant nephrotic syndrome?].
    Semeraro L.
    G Ital Nefrol; 2012; 29(6):649. PubMed ID: 23229661
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 4. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Kurupong T, Chaiyapak T, Piyaphanee N, Pattaragarn A, Sumboonnanonda A.
    J Med Assoc Thai; 2013 Jan; 96(1):33-40. PubMed ID: 23720975
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of Efficacy of Tacrolimus Versus Cyclosporine in Childhood Steroid-Resistant Nephrotic Syndrome.
    Shah SS, Hafeez F.
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):589-93. PubMed ID: 27504551
    [Abstract] [Full Text] [Related]

  • 10. Diltiazem used as a tacrolimus-sparing agent for treatment of pediatric patients with refractory nephrotic syndrome: a case report and retrospective analysis.
    Sun JY, Hu YH, Guo HL, Jing X, Xu ZJ, Sun F, Guo HL, Ding XS, Chen F, Xu J.
    Eur J Clin Pharmacol; 2019 Apr; 75(4):591-593. PubMed ID: 30483827
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment.
    Oh J, Kemper MJ.
    Minerva Pediatr; 2012 Apr; 64(2):197-204. PubMed ID: 22495193
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TACROLIMUS DRUG LEVEL AND RESPONSE TO TREATMENT IN IDIOPATHIC CHILDHOOD STEROID RESISTANT NEPHROTIC SYNDROME.
    Shah SS, Hafeez F, Akhtar N.
    J Ayub Med Coll Abbottabad; 2015 Apr; 27(4):784-7. PubMed ID: 27004322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Management of steroid-resistant nephrotic syndrome in children and adolescents.
    Tullus K, Webb H, Bagga A.
    Lancet Child Adolesc Health; 2018 Dec; 2(12):880-890. PubMed ID: 30342869
    [Abstract] [Full Text] [Related]

  • 20. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.
    Ziring DA, Wu SS, Mow WS, Martín MG, Mehra M, Ament ME.
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):306-11. PubMed ID: 17873742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.